Basanite (BASA) 10-K 31 Mar 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Document And Entity Information
Entity Registrant Name	BASANITE, INC.
Entity Central Index Key	0001448705
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Auditor Attestation Flag	false
Entity Public Float			$ 36,301,886
Entity Common Stock, Shares Outstanding		226,886,785
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV
Entity File Number	000-53574

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 259,505	$ 129,152
Accounts receivable, net	1,907
Inventory	446,575	159,472
Prepaid expenses	40,283	26,640
Deposits and other current assets	75,995	145,671
TOTAL CURRENT ASSETS	824,265	460,935
Lease right-of-use asset	1,004,167	1,222,853
Fixed assets, net	1,020,035	771,996
Other assets		5,380
TOTAL LONG TERM ASSETS	2,024,202	2,000,229
TOTAL ASSETS	2,848,467	2,461,164
CURRENT LIABILITIES
Accounts payable	249,353	218,082
Accrued expenses	197,350	489,179
Accrued legal liabilities	809,127	790,606
Notes payable	128,021	219,617
Notes payable - convertible, net	10,000	453,991
Notes payable - convertible - related party, net	1,025,000
Subscription liability	40,000
Lease liability - current portion	267,289	221,997
TOTAL CURRENT LIABILITIES	2,726,140	2,393,472
Lease liability - net of current portion	826,388	1,094,970
TOTAL LIABILITIES	3,552,528	3,488,442
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding, respectively
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 224,836,785 and 200,735,730 shares issued and outstanding, respectively	224,838	200,736
Additional paid-in capital	28,714,488	24,216,042
Accumulated deficit	(29,643,387)	(25,444,056)
TOTAL STOCKHOLDERS' DEFICIT	(704,061)	(1,027,278)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 2,848,467	$ 2,461,164

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	224,836,785	200,735,730
Common stock, shares outstanding	224,836,785	200,735,730

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Revenue
Products sales - rebar	$ 7,161	$ 3,892
Total cost of goods sold	4,487	105,010
Gross profit (loss)	2,674	(101,118)
OPERATING EXPENSES
Professional fees	438,749	341,906
Payroll, taxes and benefits	837,348	865,828
Consulting fees	270,525	219,326
General and administrative	1,408,948	2,483,226
Loss on inventory obsolescence	33,062
Total operating expenses	2,988,632	3,910,286
NET LOSS FROM OPERATIONS	(2,985,958)	(4,011,404)
OTHER (EXPENSE) INCOME
Gain on sale of asset	40,838
Loss on extinguishment of debt	(56,948)
Miscellaneous income	70,817	4,469
Gain on settlement of payables	293,678	201,617
Impairment of fixed assets		(1,478)
Interest expense	(898,257)	(113,076)
Total other (expense) income	(549,872)	91,532
NET LOSS FROM OPERATIONS	(3,535,830)	(3,919,872)
Deemed dividends	(663,501)	(388,932)
NET LOSS	$ (4,199,331)	$ (4,308,804)
Net loss per share - basic and diluted	$ (0.017)	$ (0.021)
Weighted average number of shares outstanding - basic and diluted	209,163,821	186,607,492

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Subscription Receivable [Member]	Non-controlling Interest	Total
Balance, Amount at Dec. 31, 2018		$ 154,202	$ 18,718,283	$ (21,135,252)		$ 225,015	$ (2,037,752)
Balance, Shares at Dec. 31, 2018		154,202,008
Stock-based compensation			1,701,316				1,701,316
Stock-based compensation, shares
Shares issued to convert notes payable		$ 2,139	528,961				531,100
Shares issued to convert notes payable, shares		2,139,437
Stock issued for cash		$ 21,324	1,248,756				1,270,080
Stock issued for cash, shares		21,323,570
Stock issued to purchase non-controlling interest in Basalt America Territory #1		$ 2,010	223,005			(225,015)
Stock issued to purchase non-controlling interest in Basalt America Territory #1, shares		2,010,000
Warrants exercised for cash		$ 19,711	1,268,889				1,288,600
Warrants exercised for cash, shares		19,710,715
Deemed dividend on common stock			388,932				388,932
Shares issued as loan commitment fee		$ 1,350	137,900				139,250
Shares issued as loan commitment fee, shares		1,350,000
Net loss				(4,308,804)			(4,308,804)
Balance, Amount at Dec. 31, 2019		$ 200,736	24,216,042	(25,444,056)			(1,027,278)
Balance, Shares at Dec. 31, 2019		200,735,730
Convertible debt and debt discount		$ 9,306	2,008,673				2,017,979
Convertible debt and debt discount, shares		9,305,426
Stock issued for compensation		$ 600	173,400				174,000
Stock issued for compensation, shares		600,000
Stock issued for cash		$ 8,386	1,134,606				$ 1,142,992
Stock issued for cash, shares		8,385,289					7,110,340
Warrants exercised for cash		$ 7,110	646,966				$ 654,076
Warrants exercised for cash, shares		7,110,340
Deemed dividend on common stock			663,501				663,501
Return of shares issued with loan commitment fee		$ (1,300)	(128,700)				(130,000)
Return of shares issued with loan commitment fee, shares		(1,300,000)
Net loss				(4,199,331)			(4,199,331)
Balance, Amount at Dec. 31, 2020		$ 224,838	$ 28,714,488	$ (29,643,387)			$ (704,061)
Balance, Shares at Dec. 31, 2020		224,836,785

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,199,331)	$ (4,308,804)
Adjustments to reconcile net loss to net cash used in operating activities:
Lease right-of-use asset amortization	218,686	175,920
Depreciation	117,340	17,143
Amortization of debt discount	707,533	(22,533)
Gain on extinguishment of debt	56,948
Loss on sale of asset	(40,838)
Impairment of fixed assets		1,478
Loss on inventory obsolescence	33,062
Non-cash interest charges		(81,806)
Non-cash loan commitment fee		9,250
Deemed dividend	663,501	388,932
Stock-based compensation	165,590	1,701,316
Changes in operating assets and liabilities:
Prepaid expenses	(5,233)	56,537
Inventory	(320,165)	(102,886)
Accounts receivable	(1,907)	883
Subscription liability	40,000
Lease liability	(223,290)
Deposits and other current assets	49,263	(127,051)
Accounts payable and accrued expenses	(60,658)	32,084
Net cash used in operating activities	(2,799,499)	(2,259,537)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(339,586)	(766,918)
Deposits on machinery and equipment		200,000
Net cash used in investing activities	(339,586)	(566,918)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock and exercise of warrants	1,797,068	2,392,828
Repayment of convertible notes payable and convertible notes payable related party	(348,000)	(104,704)
Proceeds from notes payable and notes payable related party	266,727	234,760
Proceeds from convertible notes payable and convertible notes payable related party	1,620,000	408,000
Repayment of notes payable and notes payable related party	(66,357)	(97,108)
Net cash provided by financing activities	3,269,438	2,833,776
NET INCREASE IN CASH	130,353	7,321
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	129,152	121,831
CASH AND CASH EQUIVALENTS AT END OF PERIOD	259,505	129,152
Supplemental cash flow information:
Cash paid for interest expense	35,723	31,237
Supplemental disclosure of non cash investing and financing activities:
Return of loan commitment shares	(130,000)
Common shares issued for loan commitment fees		137,900
Conversion of notes payable into common stock	150,000	531,101
Recording of debt discount on convertible notes	685,000
Conversion of convertible notes payable into common stock	1,182,979
Common shares issued to acquire interest in joint venture		502,500
Exchange of notes payable and related interest for common stock		$ 165,852

ORGANIZATION, NATURE OF BUSINES

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (A) Description of Business On May 30, 2006, Basanite, Inc. was organized as a Nevada corporation. Basanite and its wholly owned subsidiaries are herein referred to as the "Company", “we”, “our”, or “us”. Currently based in Pompano Beach, Florida, the Company intends to manufacture concrete-reinforcing products made from basalt fiber reinforced polymers (“BFRP”), such as its primary product BasaFlex. This UV-stable, chemical, acid and moisture resistant material is sustainable and environmentally friendly and has been engineered to replace steel as it never rusts, therefore, addressing the industry’s current corrosion issues. The Company’s wholly owned subsidiary created in 2018, Basanite Industries, LLC (“BI”) manufactures BasaFlex™, a basalt fiber reinforced polymer rebar. BFRP rebar is a stronger, lighter, sustainable, non-conductive and non-corrosive alternative for traditional steel rebar and wire mesh. BI leases a fully permitted and Underwriters Laboratories (“UL”) approved 36,900 square foot facility located in Pompano Beach, Florida, equipped with five customized Pultrusion machines. Each machine has two linear production lines (a total capacity of 10 manufacturing lines). BI’s operations team is currently in the processes of optimizing and scaling the manufacturing plant to produce 11,000 to 17,000 linear feet of BFRP rebar per line, per day, depending on the product mix. BI’s own fully equipped test lab is utilized to evaluate, validate and verify each product’s performance attributes. The manufacture of concrete reinforcement products made from continuous basalt fiber creates substantial benefits for the construction industry, including but not limited to, the following: · BasaFlex ™ – · BasaFlex ™ – “ ” · BasaFlex ™ – (B) Liquidity and Management Plan Since inception, the Company has incurred net operating losses and used cash in operations. As of December 31, 2020 and 2019, respectively, the Company reported: · an accumulated deficit of approximately $29.6 million and $25.4 million; · a working capital deficiency of approximately $1.9 million and $1.9 million; and · cash used in operations of approximately $2.8 million and $2.3 million. Losses have principally occurred as a result of the substantial resources required for product research and development and for marketing of the Company's products; including the general and administrative expenses associated with the organization. At December 31, 2020, the Company had cash of $259,505 compared to $129,152 at December 31, 2019. We have historically satisfied our working capital requirements through the sale of restricted common stock and the issuance of warrants and promissory notes. Until we are able to internally generate positive cash flow, we will attempt to fund working capital requirements through third party financing, including through private placement of our securities as well as bridge loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides the opportunity for the Company to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (A) Use of Estimates in Financial Statements The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of our common stock, risk-free interest rates and the expected dividend yield of our common stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment. (B) Principles of Consolidation The consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC, formerly known as Rockstar Acquisitions, LLC. All intercompany balances have been eliminated in consolidation. (C) Cash The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company ("FDIC") up to $250,000. The Company's credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits. (D) Inventories The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at the lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists primarily of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. During the year ended December 31, 2020, the Company recorded a loss related to obsolete inventory in the amount of $33,062. No impairment charge or loss due to obsolescence were recorded during the year ended December 31, 2019. The Company’s inventory at December 31, 2020 and 2019 was comprised of: December 31, December 31, 2019 Finished goods $ 305,550 $ 47,462 Work in process 35,286 — Raw materials 105,739 112,010 Total inventory $ 446,575 $ 159,472 (E) Fixed assets Fixed assets are stated at cost, subject to adjustments for impairment, less accumulated depreciation and amortization. Depreciation and amortization are computed using a straight-line method over the following estimated useful lives: Computer equipment 3 years Machinery 7 years Leasehold improvements 15 years or lease term Office furniture and equipment 5 years Land improvements 15 years Website development 3 years Maintenance and repairs are charged to expenses as incurred, and improvements to leased facilities and equipment are capitalized. Fixed assets consist of the following: December 31, December 31, 2019 Computer equipment $ 15,780 $ 7,268 Machinery 667,536 578,347 Leasehold improvements 161,579 137,217 Office furniture and equipment 71,292 62,926 Land improvements 7,270 7,270 Website development 2,500 27,275 Construction in process 234,950 — Total fixed assets 1,160,907 820,303 Accumulated depreciation (140,872 ) (48,307 ) Total fixed assets, net $ 1,020,035 $ 771,996 Depreciation expense for the year ended December 31, 2020 was $117,340 compared to $17,143 for the year ended December 31, 2019. The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. (F) Deposits and other current assets The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service. The Company reclassified $31,173 of deposits from December 31, 2019 into machinery during the year ended December 31, 2020. (G) Accrued expenses The Company’s accrued expenses consist of the following: December 31, December 31, 2019 Accrued payroll and taxes $ 76,031 $ 321,328 Accrued interest 88,147 98,091 Credit cards payable 4,752 49,715 Other accrued expenses 28,420 20,045 Total accrued expenses $ 197,350 $ 489,179 (H) Accrued legal liabilities The Company’s accrued legal liabilities consist of the following: December 31, December 31, 2019 Accrued consulting fees $ 315,000 $ 315,000 Judgement payable 388,867 388,867 Accrued interest on judgement 105,260 86,739 Total accrued legal liability $ 809,127 $ 790,606 (I) Loss Per Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The following are potentially dilutive shares not included in the loss per share computation: December 31, December 31, 2019 Options 4,542,500 5,042,500 Warrants 38,920,378 29,849,761 Convertible shares 112,233,406 984,014 155,696,284 35,876,275 (J) Stock-Based Compensation The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company entered into a consulting agreement on July 9, 2020 for services in exchange for restricted common stock as compensation for the consulting services. The term of the agreement is for six months with the option for renewal quarterly. Upon execution of the agreement, 600,000 shares were due within 5 days of execution. The execution date fair value of the shares was $0.29 per share or $174,000. The Company recognized $165,590 in stock-based compensation as of December 31, 2020 as a result with the remainder in prepaid expense. If the Company agrees to renew each quarter, an additional 350,000 shares are to be issued per quarter. On January 9, 2021, the Company agreed to renew another quarter and issued 350,000 restricted common shares. The Company entered into a consulting agreement on October 13, 2020 for services in exchange for restricted common stock as compensation for the consulting services. The term of the agreement is for six months with the option for renewal quarterly. Upon execution of the agreement, no shares were due to be issued. If the Company agrees to renew each quarter, 250,000 shares are to be issued per quarter. On January 9, 2021, the Company agreed to renew another quarter and issued 250,000 restricted common shares. The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the years ended December 31, 2020 and 2019: 2020 2019 Expected price volatility — 118.66 - 152.63 % Risk-free interest rate — 2.32 - 2.41 % Expected life in years — 4 - 10 Dividend yield — — (K) Income Taxes The Company has not recorded any income tax expense or benefit for the years ended December 31, 2020 and 2019 due to its history of net operating losses. The provision for income taxes was calculated as a result of the following (in thousands): December 31, 2020 2019 Federal tax at statutory rate $ (743 ) $ (823 ) State taxes, net of federal income tax benefit — (171 ) Change of valuation allowance 731 987 Non-deductible expenses and other 12 7 Provision for income tax $ — $ — The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands): December 31, 2020 2019 Deferred tax assets: Net operating loss carryforwards $ 4,413 $ 3,610 Accruals and allowances 34 10 Stock-based compensation 1,070 1,059 Total deferred tax assets 5,517 4,679 Valuation allowance (5,517 ) (4,679 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: Property, equipment and intangible assets (180 ) (57 ) Total deferred tax liabilities (180 ) (57 ) Valuation allowance 180 57 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ — As of December 31, 2020, the Company has a valuation allowance of approximately $5.3 million related to federal net operating loss (“NOL”) carryforwards of approximately $21.0 million. The amount of the valuation allowance represented an increase of approximately $0.7 million over the amount recorded as of December 31, 2019 and was due to the increase in net operating losses. If not utilized, federal net operating losses of $8.0 million may be carried forward indefinitely, and $13 million will expire at various times between 2031 and 2037. State net operating losses follow the federal tax laws for NOLs. Management has evaluated all other tax positions that could have a significant effect on the financial statements and determined the Company had no uncertain income tax positions at December 31, 2020. The Company files income tax returns in the U.S. federal jurisdiction and Florida. The Company is subject to U.S. federal and Florida state tax examinations for certain years after 2018.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2020
Accounting Standards Update and Change in Accounting Principle [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS There are several new accounting pronouncements issued or proposed by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe any of these accounting pronouncements has had or will have a material impact on the Company’s consolidated financial position or operating results. In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and other Options (Subtopic 70-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s instruments by removing major separation models required under current U.S. GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exceptions and also simplifies the diluted earnings per share calculation in certain areas. The standard is effective for public business entities, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years and interim periods within those fiscal years beginning after December 15, 2021. For all other entities, the standard will be effective for fiscal years beginning after December 12, 2023. Early adoption is permitted but no earlier than fiscal years beginning after December 15, 2020, and adoption must be as of the beginning of the Company’s annual fiscal year. The Company is currently evaluating the impact that adoption of this standard will have on its consolidated financial statements and related disclosures.

OPERATING LEASE

OPERATING LEASE	12 Months Ended
	Dec. 31, 2020
Lessee Disclosure [Abstract]
OPERATING LEASE	NOTE 4 – OPERATING LEASE On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term. In accordance with ASC 842, on January 18, 2019, the Company entered into and recorded a lease right-of-use asset and a lease liability at a present value of $1,405,804. The right-of-use asset is composed of the sum of all lease payments plus any initial direct cost and is amortized over the life of the expected lease term. For the expected term of the lease, the Company used the initial term of the five-year lease. If the Company does elect to exercise its option to extend the lease for another five years, that election will be treated as a lease modification and the lease will be reviewed for remeasurement. The future minimum lease payments to be made under the operating lease as of December 31, 2020 are: 2021 $ 415,033 2022 427,484 2023 440,308 2024 110,884 Total minimum lease payments 1,393,709 Discount (300,032 ) Operating lease liability $ 1,093,677 Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used the incremental borrowing rate based on the information available at the lease commencement date. As of December 31, 2020, the weighted-average remaining lease term is 3.25 years and the weighted-average discount rate used to determine the operating lease liability was 15.0%.

NOTES PAYABLE - CONVERTIBLE

NOTES PAYABLE - CONVERTIBLE	12 Months Ended
	Dec. 31, 2020
Notes Payable, by Type, Current and Noncurrent [Abstract]
NOTES PAYABLE - CONVERTIBLE	NOTE 5 – NOTES PAYABLE – CONVERTIBLE Notes payable – convertible totaled $10,000 and $453,991 at December 31, 2020 and December 31, 2019, respectively. On October 22, 2015, the Company issued an unsecured promissory note in the principal amount of $300,000 to PDQ Auctions, LLC. The note bears interest at an annual rate of 7% and was originally payable on or before October 22, 2017 (subsequently extended until May 2021), unless the note was converted or prepaid prior to the maturity date. Subject to certain limitations, the note may be converted at any time, at the option of the holder, into shares of the Company’s common stock at a conversion price of $0.35 per share, subject to adjustment. In the event the Company issues any new or additional promissory notes that pay an interest rate that exceeds 7% per annum (subsequently increased to 10% and then to 15%), then the holder shall be entitled to request an increase in the interest rate payable on the note to an amount equal to the rate being paid on the new or additional notes. The conversion of the note may be limited if, upon conversion, the holder thereof would beneficially own more than 4.9% of the Company’s common stock. The note may be prepaid at the option of the Company commencing 190 days after the issuance of the note. On May 2, 2018, the Company secured a three-year extension of the convertible note in return for (1) a $5,000 per month payment applicable to current interest and principal beginning on April 22, 2018, and (2) the issuance of 274,575 new, restricted common shares. The shares were issued on June 13, 2018. On August 3, 2020, the Company negotiated with the noteholder to agree to convert the remaining principal balance of $258,524 and accrued interest of $102,176, at a conversion price of $0.175 per share, for 2,061,143 restricted common shares. The conversion resulted in a loss on extinguishment of debt in the amount of $121,607. On October 10, 2019, the Company entered into a Securities Purchase Agreement with Labrys Fund, LP (the investor) pursuant to which the investor purchased a 15% Convertible Promissory Note from the Company. Unless there is a specific event of default or the note remains unpaid by April 16, 2020 (the maturity date), then the investor shall have the ability to convert the principal and interest under the note into shares of the Company's common stock. If the note is not repaid prior to the maturity date, the per share conversion price into which the principal amount and interest under the note may be converted is equal to the lesser of (i) 60% multiplied by the lowest trade price of the common stock during the 25 consecutive trading days ending on the latest complete trading day prior to the date of issuance of the note, and (ii) 60% multiplied by the lowest market price of the common stock during the 25 trading day period ending on the latest complete trading day prior to the conversion date. On March 5, 2020, the Company issued a convertible promissory note to an accredited investor in exchange for $50,000 bearing an interest rate of 10% per annum and payable in nine months. After June 5, 2020, the holder may convert the unpaid principal and interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to 80% of the closing price on June 5, 2020 per share. At the time of conversion, the Company shall immediately also issue a five-year warrant to the holder to purchase an amount of warrants equal to the $50,000 divided by the conversion price of shares of common stock of the Company. The exercise price for such warrants shall be 3 times the conversion price. In addition, the warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above the warrant price times 190% for 20 consecutive trading days. The conversion price was determined to be $0.132. A debt discount of $50,000 was recorded on the note payable at resolution of the contingent beneficial conversion feature. The noteholder converted the promissory note of $50,000 and accrued interest of $1,908 on July 21, 2020 in exchange for 393,246 restricted common shares and 126,263 five-year warrants with an exercise price of $0.396 per share. On April 13, 2020, the Company entered into several convertible promissory notes. The Company issued convertible notes payable in exchange for $100,000 bearing an interest rate of 12% per annum and payable in six months. At the option of the holders, the principal and accrued interest may be converted to shares of common stock at a conversion rate of $0.092 per share. At the time of conversion, the Company shall immediately also issue an equal amount of five-year warrants to purchase common stock of the Company, at an exercise price of $0.312 per share. The warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above $0.69 per share for 20 consecutive trading days. Upon issuance of the notes, the Company recorded debt discounts of $100,000 for the beneficial conversion features embedded in the notes. One of the noteholders converted their promissory note of $50,000 and accrued interest of $1,181 on June 26, 2020 in exchange for 556,313 restricted common shares and 556,313 five-year warrants with an exercise price of $0.312 per share. The remaining noteholders converted their promissory notes of $25,000 and accrued interest of $1,618 each on July 21, 2020. Each received in exchange for their notes 280,532 restricted common shares and 280,532 five-year warrants with an exercise price of $0.312 per share. On April 13, 2020, the Company issued a convertible promissory note to an accredited investor in exchange for $50,000 bearing an interest rate of 12% per annum and payable in six months. After June 5, 2020, the holder may convert the unpaid principal and interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to 80% of the closing price on June 5, 2020 per share. At the time of conversion, the Company shall immediately also issue a five-year warrant to the holder to purchase the same number of shares of common stock of the Company as the holder receives in such conversion. The exercise price for such warrants shall be 3 times the conversion price. In addition, the warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above the warrant price plus 150% for 20 consecutive trading days. The conversion price was determined to be $0.132. A debt discount of $50,000 was recorded on the note payable at resolution of the contingent beneficial conversion feature. The noteholder converted the promissory note of $50,000 and accrued interest of $1,615 on July 21, 2020 in exchange for 391,023 restricted common shares and 391,023 five-year warrants with an exercise price of $0.396 per share. On May 27, 2020, the Company issued a convertible promissory note with an accredited investor in exchange for $60,000 bearing an interest rate of 12% per annum and payable in six months. At the option of holder, the principal may be converted to shares of common stock at a conversion rate of $0.11 per share. At the time of conversion, the Company shall immediately also issue an equal amount of five-year warrants to purchase common stock of the Company, at an exercise price of $0.33 per share. The warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above $0.825 per share for 20 consecutive trading days. Upon issuance of the note, the Company recorded a debt discount of $60,000 for the beneficial conversion features embedded in the note. The noteholder converted the promissory note on June 26, 2020 in exchange for 545,455 restricted common shares and 545,455 five-year warrants with an exercise price of $0.33 per share. Accrued interest of $552 was forgiven and reported as a gain on extinguishment of debt. On May 29, 2020, the Company issued a convertible promissory note with an accredited investor in exchange for $50,000 bearing an interest rate of 12% per annum and payable in six months. At the option of holder, the principal may be converted to shares of common stock at a conversion rate of $0.108 per share. At the time of conversion, the Company shall immediately also issue an equal amount of five-year warrants to purchase common stock of the Company, at an exercise price of $0.324 per share. The warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above $0.81 per share for 20 consecutive trading days. Upon issuance of the note, the Company recorded a debt discount of $50,000 for the beneficial conversion features embedded in the note. The noteholder converted the promissory note of $50,000 on June 26, 2020 in exchange for 462,963 restricted common shares and 462,963 five-year warrants with an exercise price of $0.324 per share. Accrued interest of $427 was forgiven and reported as a gain on extinguishment of debt. On June 1, 2020, the Company issued two convertible promissory notes with accredited investors in exchange for $100,000 bearing an interest rate of 12% per annum and payable in six months. At the option of holder, the principal may be converted to shares of common stock at a conversion rate of $0.096 per share. At the time of conversion, the Company shall immediately also issue an equal amount of five-year warrants to purchase common stock of the Company, at an exercise price of $0.288 per share. The warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above $0.72 per share for 20 consecutive trading days. Upon maturity, the Company shall have the option to convert the unpaid principal balance of the note under the same terms as above. Upon issuance of the notes, the Company recorded debt discounts of $100,000 for the beneficial conversion features embedded in the notes. The noteholders converted the promissory notes of $100,000 on December 1, 2020 in exchange for 520,834 restricted common shares and 520,834 five-year warrants with an exercise price of $0.288 per share each. Accrued interest of $5,986 was forgiven pursuant to the conversion terms of the notes. On August 3, 2020, Interest expense for the Company’s convertible notes payable was $64,093 and $51,015 for the years ended December 31, 2020 and December 31, 2019, respectively. Accrued interest for the Company’s convertible notes payable at December 31, 2020 and December 31, 2019 was $760 and $86,520, respectively, and is included in accrued expenses on the consolidated balance sheets.

NOTES PAYABLE - CONVERTIBLE - R

NOTES PAYABLE - CONVERTIBLE - RELATED PARTY	12 Months Ended
	Dec. 31, 2020
Notes Payable, by Type, Current and Noncurrent [Abstract]
NOTES PAYABLE - CONVERTIBLE - RELATED PARTY	NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY Notes payable – convertible – related party totaled $1,025,000 and $0 at December 31, 2020 and December 31, 2019, respectively. On April 13, 2020, the demand notes payable entered on January 16, 2020 for $50,000 each from related parties; Michael V. Barbera, our Board Chairman and an entity managed by Ronald J. LoRicco, Sr., a Board Member were exchanged for convertible notes. The notes were accounted for as an extinguishment and the convertible debt valued at fair value in accordance with ASC 470. Per the addendums, the interest rate of 10% was increased to 12% per annum. The modification also allowed for a conversion option for the holder after June 5, 2020. After June 5, 2020, the holder may convert the unpaid principal and interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to 80% of the closing price on June 5, 2020 per share. At the time of conversion, the Company shall immediately also issue a five-year warrant to the holder to purchase the same number of shares of common stock of the Company as the holder receives in such conversion. The exercise price for such warrants shall be 3 times the conversion price. In addition, the warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above the warrant price plus 150% for 20 consecutive trading days. The conversion price was determined to be $0.132. Debt discounts of $100,000 were recorded on the notes payable at resolution of the contingent beneficial conversion feature. One noteholder converted the promissory note of $50,000 and accrued interest of $2,440 on June 26, 2020 in exchange for 397,269 restricted common shares and 397,269 five-year warrants with an exercise price of $0.396 per share. The other noteholder converted the promissory note of $50,000 and accrued interest of $2,826 on July 21, 2020 in exchange for 400,195 restricted common shares and 400,195 five-year warrants with an exercise price of $0.396 per share. On April 13, 2020, the Company issued a convertible promissory note with Michael V. Barbera, our Board Chairman, in exchange for $25,000 bearing an interest rate of 12% per annum and payable in six months. After June 5, 2020, the holder may convert the unpaid principal and interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to 80% of the closing price on June 5, 2020 per share. At the time of conversion, the Company shall immediately also issue a five-year warrant to the holder to purchase the same number of shares of common stock of the Company as the holder receives in such conversion. The exercise price for such warrants shall be 3 times the conversion price. In addition, the warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above the warrant price plus 150% for 20 consecutive trading days. The conversion price was determined to be $0.132. A debt discount of $25,000 was recorded on the note payable at resolution of the contingent beneficial conversion feature. The noteholder converted the promissory note of $25,000 and accrued interest of $809 on July 21, 2020 in exchange for 195,522 restricted common shares and 195,522 five-year warrants with an exercise price of $0.396 per share. On April 13, 2020, the Company issued a convertible promissory note with an entity managed by Ronald J. LoRicco, Sr., a member of our Board of Directors, in exchange for $150,000 bearing an interest rate of 12% per annum and payable in six months. After June 5, 2020, the holder may convert the unpaid principal and interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to 80% of the closing price on June 5, 2020 per share. At the time of conversion, the Company shall immediately also issue a five-year warrant to the holder to purchase the same number of shares of common stock of the Company as the holder receives in such conversion. The exercise price for such warrants shall be 3 times the conversion price. In addition, the warrants shall have an option whereby the Company can require the exercise of the warrants if the trading price is at or above the warrant price plus 150% for 20 consecutive trading days. The conversion price was determined to be $0.132. A debt discount of $150,000 was recorded on the note payable at resolution of the contingent beneficial conversion feature. The noteholder converted the promissory note of $150,000 and accrued interest of $3,542 on June 26, 2020 in exchange for 1,163,201 restricted common shares and 1,163,201 five-year warrants with an exercise price of $0.396 per share. On August 3, 2020, On August 3, 2020, the Company issued a secured convertible promissory note to certain accredited investors in exchange for $1,000,000 bearing an interest rate of 20% per annum and payable in six months. The Company shall pay interest on the unconverted and then outstanding principal amount of the note at a rate of 20% per annum, accrued monthly for the first four months of this note and payable thereafter until the maturity date of February 3, 2021, unless the note is converted or prepaid prior to maturity. The holder may convert the unpaid principal balance of the note into restricted common stock, par value $0.001 per share, of the Company at the conversion rate equal to the per share cash price paid for the shares by any third-party investor(s) with total proceeds to the Company of not less than $500,000 (the “conversion price”); provided, however, in no event shall the conversion price ever be less than $0.01 per share. Interest expense for the Company’s convertible notes payable – related parties was $93,736 and $4,704 for the years ended December 31, 2020 and December 31, 2019, respectively. Accrued interest for the Company’s convertible notes payable – related parties at December 31, 2020 and December 31, 2019 was $86,574 and $0, respectively, and is included in accrued expenses on the consolidated balance sheets.

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2020
Notes Payable [Abstract]
NOTES PAYABLE	NOTE 7 – NOTES PAYABLE Notes payable totaled $128,021 and $219,617 at December 31, 2020 and December 31, 2019, respectively. During the year ended December 31, 2018, the Company issued unsecured, 4% demand promissory notes to VCVC, LLC (“VCVC”) totaling $260,425. VCVC is the personal holding company of Vincent L. Celentano, who was our chairman and chief executive officer at the time of the notes. On July 8, 2020, the Company negotiated with the noteholder to agree to settle the remaining principal balance of $191,965 and accrued interest of $15,729 for $150,000 of restricted common shares. The remaining balance of $57,694 was forgiven resulting in a gain from the extinguishment of debt. The conversion price of $0.132 per share was agreed upon for 1,136,364 restricted common shares and an equal amount of five-year warrants with an exercise price of $0.396 per share. On September 3, 2019, the Company entered a financing arrangement with their landlord to borrow against their rent payments. The financing has an interest rate of 7% and lasted through May of 2020. The balance as of December 31, 2020 was $0. On March 30, 2020 and May 17, 2019, the Company entered financing arrangements to finance the insurance premiums for its liability coverage. The financings have an interest rate of 9.40% and last through March of 2021. The balance as of December 31, 2020 was $4,703. Due to the ongoing uncertainty about the severity and duration associated with the COVID-19 pandemic, the Company considered furloughing or eliminating employees and taking other measures to reduce operating costs until there is more certainty about the short-term and long-term effects of the COVID-19 pandemic on the nation’s economy and the Company’s business. On May 1, 2020, the Company entered a promissory note agreement with its bank in exchange for $123,318 bearing an interest rate of 1.0% per annum. The loan was made pursuant to the Paycheck Protection Program under the CARES Act after receiving confirmation from the U.S. Small Business Administration (“SBA”). The Paycheck Protection Program Flexibility Act requires that the funds be used to maintain the current number of employees as well as cover payroll-related costs, monthly mortgage or rent payments and utilities and not more than 40% can be expended on non-payroll-related costs. After providing documented evidence of the number of employees and the use of funds, the SBA has forgiven the promissory note of $123,318 as of January 4, 2021. Interest expense for the Company’s notes payable was $5,041 and $7,675 for the years ended December 31, 2020 and 2019, respectively. Accrued interest for the Company’s notes payable at December 31, 2020 and December 31, 2019 was $0 and $11,244, respectively, and is included in accrued expenses on the consolidated balance sheets.

NOTES PAYABLE - RELATED PARTY

NOTES PAYABLE - RELATED PARTY	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
NOTES PAYABLE - RELATED PARTY	NOTE 8 – NOTES PAYABLE – RELATED PARTY Notes payable – related party totaled $0 at December 31, 2020 and December 31, 2019. On January 16, 2020, the Company entered into a demand note agreement with our Board Chairman, Michael V. Barbera, in the amount of $50,000. The note has a term of 6 months bearing an interest rate of 10% per annum. On April 13, 2020, an addendum was executed changing the terms of the note to a convertible note payable bearing an interest rate of 12% per annum. Per the addendum, the principal and accrued interest is convertible at the option of the holder after June 5, 2020 at a 20% discount of that days’ closing price. See Note 6 for information regarding this convertible note payable – related party. On January 16, 2020, the Company entered into a demand note agreement with an entity managed by Ronald J. LoRicco, Sr., a member of our Board of Directors, in the amount of $50,000. The note has a term of 6 months bearing an interest rate of 10% per annum. On April 13, 2020, an addendum was executed changing the terms of the note to a convertible note payable bearing an interest rate of 12% per annum. Per the addendum, the principal and accrued interest is convertible at the option of the holder after June 5, 2020 at a 20% discount of that days’ closing price. See Note 6 for information regarding this convertible note payable – related party. Interest expense for the Company’s notes payable – related party was $2,455 and $2,926 for the years ended December 31, 2020 and December 31, 2019, respectively. Accrued interest for the Company’s notes payable – related party at December 31, 2020 and December 31, 2019 was $0 and $0, respectively, and is included in accrued expenses on the consolidated balance sheets.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 – COMMITMENTS AND CONTINGENCIES Legal Matters In the ordinary course of operations, the Company may become a party to legal proceedings. Based upon information currently available, management believes that such legal proceedings, individually or in the aggregate, will not have a material adverse effect on the Company's business, financial condition, cash flows, or results of operations except as provided below. CalSTRS Judgement On March 31, 2014, the Company received a “Notice of Default” letter from legal counsel representing the California State Teachers Retirement System (“CalSTRS”) (the landlord for the Company’s office space) alerting that the Company was in default of its lease for failure to pay monthly rent for the office space located at 2400 East Commercial Boulevard, Suite 612, Fort Lauderdale, FL 33304. The letter demanded immediate payment of $41,937 for rent past due as of April 1, 2014. The Company had indicated in writing its intention to cooperate with the landlord while trying to resolve the matter. On February 11, 2015, the landlord, through its attorneys, filed a motion for summary judgment. The motion asked for $376,424 in unpaid rent, recovery of abated rents and tenant improvements and $12,442 in attorney’s costs incurred by the landlord. On April 22, 2015, the motion for unpaid rent, recovery of abated rents and tenant improvements and attorney’s costs was granted by the Circuit Court of the 17th Judicial Circuit in and for Broward County and the Company has reserved the entire judgement of $388,866. The total amount is accruing interest at the statutory rate of 4.75%. The accrued interest on the judgement at December 31, 2020 is $105,260. HLM Paymeon Storefront Damage Settlement On December 15, 2016, a third-party driver drove his car through the Company’s retail storefront located at 2599 N. Federal Highway, Fort Lauderdale, FL 33305. The accident caused severe damage to the building causing the city of Fort Lauderdale to declare the building an unsafe structure. The Company was forced to vacate the premises, therefore, terminating the lease. The damaged storefront and terminated lease effectively terminated the business. On August 3, 2017, the Company filed a complaint with the Circuit Court of the 17 th RAW Materials Litigation On or about August 28, 2018, Raw Energy Materials Corp. filed an action for declaratory relief and breach of contract in Broward County, Florida, in the 17 th An Amended Complaint was filed on or about December 19, 2018 adding Basanite Industries, LLC as a defendant, as well as an alleged claim under Florida Statute Section 501.201 and for injunction. The Company continues to contest plaintiff's claims vigorously. The Company filed and has pending an amended counterclaim for Breach of Contract, Fraud and Civil Conspiracy against Raw Energy affiliates, including Don Smith, his longtime girlfriend Elina Jenkins, Global Energy Sciences, LLC, Yellow Turtle Design, LLC, as well as former business affiliates/associates to Don Smith, Richard Laurin and Robert Ludwig. The defendants responded with a Motion to Dismiss, which was later denied. The nature of the dispute is based on representations (or misrepresentations) the Company alleges were made to it, as well as breaches of the terms of a licensing agreement, related consulting and other agreements, and failures and refusals of Plaintiff and Don Smith related entities to deliver equipment/machinery and goods paid for by the Company or its affiliates. As it became apparent that the subject license agreement was effectively worthless and moot to the Company, and the purported and promised trade secrets and intellectual property were essentially non-existent, the Company and Plaintiff agree to an order terminating that license agreement, which resulted in the Agreed Order dated January 28, 2019. The parties continue to litigate damages arising from the dispute. A mediation was scheduled on March 4, 2021 which resulted in an impasse. Negotiations towards a settlement are ongoing. Lustig Litigation In reviewing court records recently in late 2020, counsel for the Company found names of its affiliates in a case filed in 2018 by Stephen Lustig against one of the Company's shareholders. The Company and its affiliates were not served or made a party to that case; and were listed as an attempt by Mr. Lustig to execute, attach or foreclosure on the defendant shareholder's stock in the Company. The Company did not breach any agreement and was not engaged in any wrongdoing. The Company was informed that the subject shareholder had made contact with Mr. Lustig and obtained a resolution between them; a voluntary dismissal was filed on January 4, 2021. To our knowledge, we are not currently subject to any other legal proceedings. Supplier Agreement MEP Consulting Engineers, Inc. On July 23, 2020, the Company entered into an Exclusive Supplier Agreement with MEP Consulting Engineers, Inc. (“MEP”) of Miami, FL. MEP engaged the Company as its sole and exclusive supplier for production of MEP’s proprietary “Hurricane Bar,” a BFRP reinforcing bar product owned by MEP. The agreement also provides MEP with exclusive distribution rights to the Company’s BasaFlex TM The agreement allows for MEP or its designated customers to place orders from time to time for up to the total value of $50,000,000 over the 5-year period. As compensation, MEP was provided the ability to exercise options to purchase a total of 5,000,000 restricted common shares of the Company, over the 5 years from the supplier agreement effective date, tied to sales performance. This option shall automatically expire after the end of the option period. An extension period is available through specific clauses in the agreement. To date, the compensation portion of the agreement has not been fully executed. CR Business Consultants, Inc. On October 22, 2020, the Company entered into an Exclusive Supplier Agreement with CR Business Consultants, Inc. (“CRBC”). CRBC agreed to utilize the Company as its exclusive supplier for all Basanite products, and the Company has granted CRBC exclusive distribution rights of the Company’s products in the Republic of Costa Rica and the and Republic of Panama. CRBC also has non-exclusive distribution rights in the Republic of El Salvador; Belize; the Republic of Guatemala; the Republic of Honduras; and the Republic of Nicaragua; Argentina, Plurinational State of Bolivia, Federative Republic of Brazil, Republic of Chile, Republic of Colombia, Republic of Ecuador, Co-operative Republic of Guyana, Republic of Paraguay, Republic of Peru, Republic of Suriname, Oriental Republic of Uruguay, Bolivarian Republic of Venezuela, and a part of France, French Guiana; and the Kingdom of the Netherlands; the Falkland; and the Republic of Trinidad and Tobago. Furthermore, CRBC can introduce additional customers to Basanite from other territories with no geographic restrictions, and where sales to such customers will be included under Terms of the Agreement. The agreement allows for CRBC or its designated customers to place orders from time to time for up to a total value of $50,000,000 over the 5-year period. As compensation, CRBC was provided the ability to exercise options to purchase a total of 5,000,000 restricted common shares of the Company, over the 5 years from the supplier agreement effective date, tied to sales performance. This option shall automatically expire after the end of the option period. An extension period is available through specific clauses in the agreement.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	12 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 10 – STOCKHOLDERS’ DEFICIT In April 2020, the Company issued 4,166,667 restricted common shares, par value $.001 per share, in exchange for the $416,667 received in the prior period from investors. The investors also received 4,000,000 five-year warrants with an exercise price of $0.30 per share and 16,667 five-year warrants with an exercise price of $0.40 per share. Additionally, 1,300,000 restricted common shares were returned to the Company upon fully satisfying the debt with Labrys Fund. See Note 5 for information regarding this note payable. In June 2020, the Company received $200,000 from investors in exchange for 912,409 restricted common shares, par value $.001 per share, for $0.1096 per share and 961,538 restricted common shares, par value $.001 per share, for $0.104 per share. Both investors received equal amounts of five-year warrants with an exercise price to be determined as the greater of: (a) three times the purchase price for the common shares pursuant to the subscription agreement; or (b) the price equal to 80% of the lowest open market closing price of the common shares during the twenty trading days preceding the 120 th calendar day after the purchase date. On August 5, 2020, an accredited investor received 163,043 restricted common shares and 163,043 five-year warrants with an exercise price of $0.54 per share in exchange for $30,000. On September 25, 2020, an accredited investor exercised his warrants at an exercise price of $0.075. The investor received 500,000 restricted common shares in exchange for $37,500. On September 28, 2020, the Company received $90,000 from an accredited investor to purchase 300,000 restricted common stock. On October 5, 2020, an accredited investor received 300,000 restricted common shares in exchange for $90,000. On October 14, 2020, an accredited investor received 166,667 restricted common shares in exchange for $50,000. On October 16, 2020, 600,000 shares were issued per the consulting agreement entered on July 9, 2020 for fundraising services. The value of the shares is $174,000 and will be expensed over the six-month term of the agreement. On October 27, 2020, an accredited investor received 133,333 restricted common shares in exchange for $40,000. On November 10, 2020, the Board of Directors approved offering the current holders of our warrants a discounted exercise price to their current exercise price if they exercised the warrant within a certain time period. The offer to the current holders of our warrant commenced on November 10, 2020 and extended through December 4, 2020 providing warrants holders with declining discounts on their exercise price per share in an effort to raise the capital required. In December, the Company issued 6,590,340 restricted common shares in exchange for $612,576 from discounted exercise of warrants and 1,601,632 restricted common shares in exchange for $320,325 from discounted private placements. In connection with the issuance of common stock, $663,501 was recognized as a deemed dividend, which represents the intrinsic value of the discounted exercise price of the warrants exercised as the holders of the warrants are also common shareholders. During the year ended December 31, 2020, the Company issued 8,385,289 restricted common shares for proceeds received in the amount of $1,142,992 from the sale of stock from accredited investors and related parties; 7,110,340 restricted common shares for proceeds in the amount of $654,076 from the exercise of warrants; 9,305,426 restricted common shares from the conversion of debt and accrued interest in the amount of $1,104,476; and 600,000 restricted common shares for payment of services. The Company also received 1,300,000 shares in return originally issued as a loan commitment fee after full repayment of a convertible note.

OPTIONS AND WARRANTS

OPTIONS AND WARRANTS	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
OPTIONS AND WARRANTS	NOTE 11 – OPTIONS AND WARRANTS Stock Options: The following table provides the activity in options for the respective periods: Total Options Outstanding Weighted Average Exercise Price Aggregate Intrinsic Value Balance at January 1, 2019 2,587,500 $ 0.35 $ — Issued 2,500,000 0.25 Cancelled (45,000 ) (0.25 ) Balance at December 31, 2019 5,042,500 $ 0.40 $ — Cancelled (500,000 ) (0.25 ) Balance at December 31, 2020 4,542,500 $ 0.41 $ 118,148 Options exercisable and outstanding at December 31, 2020 are as follows: Weighted Average Range of Remaining Weighted Average Aggregate Exercise Prices Number Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $0.01 - $0.50 2,002,500 2.66 $0.25 $ 118,148 $0.51 - $1.00 2,540,000 4.80 $0.54 — 4,542,500 $ 118,148 Stock Warrants: The following table provides the activity in warrants for the respective periods: Total Warrants Weighted Average Exercise Price Aggregate Intrinsic Value Balance at January 1, 2019 18,025,000 $ 0.24 $ — Granted 31,535,475 0.12 Exercised (19,710,714 ) 0.07 Balance at December 31, 2019 29,849,761 $ 0.23 $ 1,956,750 Granted 17,180,957 0.31 Exercised (7,110,340 ) 0.09 Cancelled (1,000,000 ) — Balance at December 31, 2020 38,920,378 $ 0.27 $ 2,973,660 Warrants exercisable and outstanding at December 31, 2020 are as follows: Weighted Average Range of Remaining Weighted Average Aggregate Exercise Prices Number Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $0.01 - $0.50 36,429,835 3.46 $0.24 $2,973,660 $0.51 - $1.00 2,490,543 2.10 $0.60 — 38,920,378 $2,973,660 During the year ended December 31, 2020, warrants to purchase 500,000 shares of common stock with an exercise price of $0.075 per share were exercised for $37,500 and warrants to purchase 6,610,340 shares of common stock with various exercises price were exercised at a 50% discount for $616,576. The total received for the exercise of warrants was $654,076, resulting in the issue of a total of 7,110,340 shares of common stock. The Company entered into a consulting agreement on December 15, 2020 for services in exchange for payment in cash and cashless warrants for the purchase of restricted common stock as compensation for the consulting services. The term of the agreement is for three months with the option for renewal quarterly. Upon execution of the agreement, $7,500 and 250,000 cashless, five-year warrants for the purchase of restricted common stock with an exercise price of $0.30 per share were due within 5 days of execution. Monthly payments of $7,500 are due for the term of the agreement. If the Company agrees to renew another quarter, payment in cash and cashless warrants for the purchase of restricted common stock as compensation is required for each quarter. During the years ended December 31, 2020 and 2019, total stock-based compensation expense amounted to $165,590

RELATED PARTIES

RELATED PARTIES	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 12 – RELATED PARTIES In addition to those transactions discussed in Notes 6 and 8, the Company had the following related party transactions. During the week of November 20, 2020, during the discounted warrant event whereby accredited investors could exercise their outstanding warrants at 50% of their stated exercise price, several related parties exercised their warrants at a discount. Paul Sallarulo, a member of our Board of Directors, exercised 2,000,000 warrants originally issued with an exercise price of $0.075 for $75,000 or $0.0375 a share. Michael V. Barbera, our Chairman of the Board, exercised 1,000,000 warrants originally issued with an exercise price of $0.075 for $37,500 or $0.0375 per share. An entity managed by Ronald J. LoRicco, Sr., a member of our Board of Directors,

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS On January 4, 2021, the Small Business Administration forgave the promissory note of $123,381 and accrued interest of $825 issued under the Paycheck Protection Program. On January 11, 2021, 600,000 shares were issued per the two consulting agreements entered on July 9, 2020 and October 16, 2020 for fundraising services. The value of the shares is $174,000 and will be expensed over the renewable three-month term of the agreement. On January 26, 2021, an accredited investor exercised 1,000,000 warrants for restricted common shares at a strike price of $0.1235 per share in exchange for $123,500. On January 26, 2021, the Company issued the 200,000 restricted common shares to the accredited investor in exchange for the subscription liability of $40,000 at December 31, 2020. On February 11, 2021, the Company issued 250,000 unrestricted common shares to an accredited investor in exchange for $50,000. On February 12, 2021, the Company issued an amended and restated secured convertible promissory note to certain accredited investors in exchange for $1,610,005 bearing an interest rate of 20% per annum and payable in three months. The original principal of $1,000,000 and accrued interest of $110,005 calculated as of the date of amendment and restatement along with an additional advance of $500,000 determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 15,000,000 five-year common stock warrants with an exercise price of $0.20. The Company shall pay interest on the unconverted and then outstanding principal amount of the note at a rate of 20% per annum at the maturity date of May 12, 2021, unless the note is converted or prepaid prior to maturity. The holder may convert the unpaid principal and accrued and unpaid interest balance of the note into shares of common stock, par value $0.001 per share, at the conversion rate equal to the per share cash price paid for the shares by any third-party investor(s) with total proceeds to the Company of not less than $500,000, however, in no event shall the conversion price ever be less than $0.01 per share. If prior to the maturity date, the Company consummates financing with proceeds of not less than $3,000,000, the noteholders, at their sole discretion, may elect to extend the maturity date by an additional six months such that the maturity date shall then be November 12, 2021. The amended and restated note contains a negative covenant that requires the Company to obtain consent prior to incurring any additional equity or debt investments and is secured by all of the assets of the Company. The Richard A. LoRicco Sr. and Lucille M. LoRicco Irrevocable Insurance Trust DTD 4/28/95, Louis Demaio as Trustee (the “Trust”) is the holder of $1,207,504 of the principal amount of this note. The Trust is maintained by Richard A. LoRicco Sr. and Lucille M. LoRicco, who are the parents of Ronald J. LoRicco Sr., one of the members of our Board. The disinterested members of the Board approved the terms of the note. Ronald J. LoRicco Sr. does not have voting or investment control of or power over the Trust but is an anticipated, partial beneficiary of the Trust. On February 12, 2021, 11,250,000 of the 15,000,000 warrants were issued to the noteholders. On February 25, 2021, the Company entered a promissory note agreement with its bank in exchange for $165,747 bearing an interest rate of 1.0% per annum. The loan was made pursuant to the Paycheck Protection Program under the Second Draw PPP Legislation after receiving confirmation from the U.S. Small Business Administration (“SBA”). The Paycheck Protection Program Flexibility Act requires that the funds be used to maintain the current number of employees as well as cover payroll-related costs, monthly mortgage or rent payments and utilities and not more than 40% can be expended on non-payroll-related costs. The applicable maturity date will be the maturity date as established by the SBA. If the SBA does not establish a maturity date or range of allowable maturity dates, the term will be five years. On March 29, 2021, an accredited investor purchased 127,128 restricted common shares from the Company in exchange for $23,900. The shares have not been issued as of the date of the report. In March of 2021, the Company received the first prototype of its customized next generation pultrusion manufacturing system. This “BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM · BasaMax TM Integration and installation of this new equipment also requires changes and upgrades to our facility, which in turn require significant capital. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. Because the Company is currently experiencing a scarcity of working capital on top of the funding needed for the facility upgrades, the Company has temporarily scaled back operations and issued temporary furloughs to certain employees to conserve its cash. No assurances can be given that the Company will be successful in raising future capital.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Use of Estimates in Financial Statements	(A) Use of Estimates in Financial Statements The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the option, the expected volatility of the price of our common stock, risk-free interest rates and the expected dividend yield of our common stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.
Principles of Consolidation	(B) Principles of Consolidation The consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC, formerly known as Rockstar Acquisitions, LLC. All intercompany balances have been eliminated in consolidation.
Cash	(C) Cash The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company ("FDIC") up to $250,000. The Company's credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.
Inventories	(D) Inventories The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at the lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists primarily of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. During the year ended December 31, 2020, the Company recorded a loss related to obsolete inventory in the amount of $33,062. No impairment charge or loss due to obsolescence were recorded during the year ended December 31, 2019. The Company’s inventory at December 31, 2020 and 2019 was comprised of: December 31, December 31, 2019 Finished goods $ 305,550 $ 47,462 Work in process 35,286 — Raw materials 105,739 112,010 Total inventory $ 446,575 $ 159,472
Fixed assets	(E) Fixed assets Fixed assets are stated at cost, subject to adjustments for impairment, less accumulated depreciation and amortization. Depreciation and amortization are computed using a straight-line method over the following estimated useful lives: Computer equipment 3 years Machinery 7 years Leasehold improvements 15 years or lease term Office furniture and equipment 5 years Land improvements 15 years Website development 3 years Maintenance and repairs are charged to expenses as incurred, and improvements to leased facilities and equipment are capitalized. Fixed assets consist of the following: December 31, December 31, 2019 Computer equipment $ 15,780 $ 7,268 Machinery 667,536 578,347 Leasehold improvements 161,579 137,217 Office furniture and equipment 71,292 62,926 Land improvements 7,270 7,270 Website development 2,500 27,275 Construction in process 234,950 — Total fixed assets 1,160,907 820,303 Accumulated depreciation (140,872 ) (48,307 ) Total fixed assets, net $ 1,020,035 $ 771,996 Depreciation expense for the year ended December 31, 2020 was $117,340 compared to $17,143 for the year ended December 31, 2019. The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Deposits and other current assets	(F) Deposits and other current assets The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service. The Company reclassified $31,173 of deposits from December 31, 2019 into machinery during the year ended December 31, 2020.
Accrued expenses	(G) Accrued expenses The Company’s accrued expenses consist of the following: December 31, December 31, 2019 Accrued payroll and taxes $ 76,031 $ 321,328 Accrued interest 88,147 98,091 Credit cards payable 4,752 49,715 Other accrued expenses 28,420 20,045 Total accrued expenses $ 197,350 $ 489,179
Accrued legal liabilities	(H) Accrued legal liabilities The Company’s accrued legal liabilities consist of the following: December 31, December 31, 2019 Accrued consulting fees $ 315,000 $ 315,000 Judgement payable 388,867 388,867 Accrued interest on judgement 105,260 86,739 Total accrued legal liability $ 809,127 $ 790,606
Loss Per Share	(I) Loss Per Share The basic loss per share is calculated by dividing the Company’s net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company’s net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The following are potentially dilutive shares not included in the loss per share computation: December 31, December 31, 2019 Options 4,542,500 5,042,500 Warrants 38,920,378 29,849,761 Convertible shares 112,233,406 984,014 155,696,284 35,876,275
Stock-Based Compensation	(J) Stock-Based Compensation The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company entered into a consulting agreement on July 9, 2020 for services in exchange for restricted common stock as compensation for the consulting services. The term of the agreement is for six months with the option for renewal quarterly. Upon execution of the agreement, 600,000 shares were due within 5 days of execution. The execution date fair value of the shares was $0.29 per share or $174,000. The Company recognized $165,590 in stock-based compensation as of December 31, 2020 as a result with the remainder in prepaid expense. If the Company agrees to renew each quarter, an additional 350,000 shares are to be issued per quarter. On January 9, 2021, the Company agreed to renew another quarter and issued 350,000 restricted common shares. The Company entered into a consulting agreement on October 13, 2020 for services in exchange for restricted common stock as compensation for the consulting services. The term of the agreement is for six months with the option for renewal quarterly. Upon execution of the agreement, no shares were due to be issued. If the Company agrees to renew each quarter, 250,000 shares are to be issued per quarter. On January 9, 2021, the Company agreed to renew another quarter and issued 250,000 restricted common shares. The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the years ended December 31, 2020 and 2019: 2020 2019 Expected price volatility — 118.66 - 152.63 % Risk-free interest rate — 2.32 - 2.41 % Expected life in years — 4 - 10 Dividend yield — —
Income Taxes	(K) Income Taxes The Company has not recorded any income tax expense or benefit for the years ended December 31, 2020 and 2019 due to its history of net operating losses. The provision for income taxes was calculated as a result of the following (in thousands): December 31, 2020 2019 Federal tax at statutory rate $ (743 ) $ (823 ) State taxes, net of federal income tax benefit — (171 ) Change of valuation allowance 731 987 Non-deductible expenses and other 12 7 Provision for income tax $ — $ — The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands): December 31, 2020 2019 Deferred tax assets: Net operating loss carryforwards $ 4,413 $ 3,610 Accruals and allowances 34 10 Stock-based compensation 1,070 1,059 Total deferred tax assets 5,517 4,679 Valuation allowance (5,517 ) (4,679 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: Property, equipment and intangible assets (180 ) (57 ) Total deferred tax liabilities (180 ) (57 ) Valuation allowance 180 57 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ — As of December 31, 2020, the Company has a valuation allowance of approximately $5.3 million related to federal net operating loss (“NOL”) carryforwards of approximately $21.0 million. The amount of the valuation allowance represented an increase of approximately $0.7 million over the amount recorded as of December 31, 2019 and was due to the increase in net operating losses. If not utilized, federal net operating losses of $8.0 million may be carried forward indefinitely, and $13 million will expire at various times between 2031 and 2037. State net operating losses follow the federal tax laws for NOLs. Management has evaluated all other tax positions that could have a significant effect on the financial statements and determined the Company had no uncertain income tax positions at December 31, 2020. The Company files income tax returns in the U.S. federal jurisdiction and Florida. The Company is subject to U.S. federal and Florida state tax examinations for certain years after 2018.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Inventories	The Company’s inventory at December 31, 2020 and 2019 was comprised of: December 31, December 31, 2019 Finished goods $ 305,550 $ 47,462 Work in process 35,286 — Raw materials 105,739 112,010 Total inventory $ 446,575 $ 159,472
Schedule of Depreciation and Amortization Periods for Fixed Assets	Depreciation and amortization are computed using a straight-line method over the following estimated useful lives: Computer equipment 3 years Machinery 7 years Leasehold improvements 15 years or lease term Office furniture and equipment 5 years Land improvements 15 years Website development 3 years
Schedule of Fixed Assets	Fixed assets consist of the following: December 31, December 31, 2019 Computer equipment $ 15,780 $ 7,268 Machinery 667,536 578,347 Leasehold improvements 161,579 137,217 Office furniture and equipment 71,292 62,926 Land improvements 7,270 7,270 Website development 2,500 27,275 Construction in process 234,950 — Total fixed assets 1,160,907 820,303 Accumulated depreciation (140,872 ) (48,307 ) Total fixed assets, net $ 1,020,035 $ 771,996
Schedule of Accrued Expenses	The Company’s accrued expenses consist of the following: December 31, December 31, 2019 Accrued payroll and taxes $ 76,031 $ 321,328 Accrued interest 88,147 98,091 Credit cards payable 4,752 49,715 Other accrued expenses 28,420 20,045 Total accrued expenses $ 197,350 $ 489,179
Schedule of Accrued Legal Liability	The Company’s accrued legal liabilities consist of the following: December 31, December 31, 2019 Accrued consulting fees $ 315,000 $ 315,000 Judgement payable 388,867 388,867 Accrued interest on judgement 105,260 86,739 Total accrued legal liability $ 809,127 $ 790,606
Schedule of Dilutive Shares Not Included in Loss Per Share Computation	The following are potentially dilutive shares not included in the loss per share computation: December 31, December 31, 2019 Options 4,542,500 5,042,500 Warrants 38,920,378 29,849,761 Convertible shares 112,233,406 984,014 155,696,284 35,876,275
Schedule of Fair Value Assumptions	The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the years ended December 31, 2020 and 2019: 2020 2019 Expected price volatility — 118.66 - 152.63 % Risk-free interest rate — 2.32 - 2.41 % Expected life in years — 4 - 10 Dividend yield — —
Schedule of Provision of Income Taxes	The provision for income taxes was calculated as a result of the following (in thousands): December 31, 2020 2019 Federal tax at statutory rate $ (743 ) $ (823 ) State taxes, net of federal income tax benefit — (171 ) Change of valuation allowance 731 987 Non-deductible expenses and other 12 7 Provision for income tax $ — $ —
Schedule of Deferred Tax Assets and Liabilities	The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities are as follows (in thousands): December 31, 2020 2019 Deferred tax assets: Net operating loss carryforwards $ 4,413 $ 3,610 Accruals and allowances 34 10 Stock-based compensation 1,070 1,059 Total deferred tax assets 5,517 4,679 Valuation allowance (5,517 ) (4,679 ) Total deferred tax assets net of valuation allowance — — Deferred tax liabilities: Property, equipment and intangible assets (180 ) (57 ) Total deferred tax liabilities (180 ) (57 ) Valuation allowance 180 57 Total deferred tax liabilities net of valuation allowance — — Net deferred tax assets $ — $ —

OPERATING LEASE (Tables)

OPERATING LEASE (Tables)	12 Months Ended
	Dec. 31, 2020
Lessee Disclosure [Abstract]
Schedule of Operating Lease Liability	The future minimum lease payments to be made under the operating lease as of December 31, 2020 are: 2021 $ 415,033 2022 427,484 2023 440,308 2024 110,884 Total minimum lease payments 1,393,709 Discount (300,032 ) Operating lease liability $ 1,093,677

OPTIONS AND WARRANTS (Tables)

OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Dec. 31, 2020
Stock Options [Member]
Schedule of Activity in Options and Warrants	The following table provides the activity in options for the respective periods: Total Options Outstanding Weighted Average Exercise Price Aggregate Intrinsic Value Balance at January 1, 2019 2,587,500 $ 0.35 $ — Issued 2,500,000 0.25 Cancelled (45,000 ) (0.25 ) Balance at December 31, 2019 5,042,500 $ 0.40 $ — Cancelled (500,000 ) (0.25 ) Balance at December 31, 2020 4,542,500 $ 0.41 $ 118,148
Schedule of Options and Warrants Exercisable and Outstanding	Options exercisable and outstanding at December 31, 2020 are as follows: Weighted Average Range of Remaining Weighted Average Aggregate Exercise Prices Number Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $0.01 - $0.50 2,002,500 2.66 $0.25 $ 118,148 $0.51 - $1.00 2,540,000 4.80 $0.54 — 4,542,500 $ 118,148
Stock Warrants [Member]
Schedule of Activity in Options and Warrants	The following table provides the activity in warrants for the respective periods: Total Warrants Weighted Average Exercise Price Aggregate Intrinsic Value Balance at January 1, 2019 18,025,000 $ 0.24 $ — Granted 31,535,475 0.12 Exercised (19,710,714 ) 0.07 Balance at December 31, 2019 29,849,761 $ 0.23 $ 1,956,750 Granted 17,180,957 0.31 Exercised (7,110,340 ) 0.09 Cancelled (1,000,000 ) — Balance at December 31, 2020 38,920,378 $ 0.27 $ 2,973,660
Schedule of Options and Warrants Exercisable and Outstanding	Warrants exercisable and outstanding at December 31, 2020 are as follows: Weighted Average Range of Remaining Weighted Average Aggregate Exercise Prices Number Outstanding Contractual Life (Years) Exercise Price Intrinsic Value $0.01 - $0.50 36,429,835 3.46 $0.24 $2,973,660 $0.51 - $1.00 2,490,543 2.10 $0.60 — 38,920,378 $2,973,660

ORGANIZATION, NATURE OF BUSIN_2

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details)	12 Months Ended
	Dec. 31, 2020USD ($)ft²shares	Dec. 31, 2019USD ($)
Restricted shares issued | shares	11,632
Restricted shares issued, value	$ 2,326
Accumulated deficit	29,643,387	$ 25,444,056
Working capital deficiency	1,900,000	1,900,000
Net cash used in operations	2,799,499	2,259,537
Cash	$ 259,505	$ 129,152
Pompano Beach, Florida [Member]
Total square foot of property | ft²	36,900

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($)	Jul. 09, 2020	Dec. 31, 2020	Dec. 31, 2019	Jul. 09, 2021	Jan. 09, 2021	Oct. 13, 2020
Cash insured amount		$ 250,000
Amount of Inventory reserve		33,062
Deposits		31,173
Stock based compensation		$ 165,590	$ 1,701,316
Consulting Agreement [Member]
Shares due	600,000
Fair value of share	$ 174,000
Fair value of per share	$ 0.29
Stock based compensation	$ 165,590
Shares to be issued	350,000					250,000
Consulting Agreement [Member] | Subsequent Event [Member]
Shares to be issued				350,000	250,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Inventory) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Finished goods	$ 305,550	$ 47,462
Work in process	35,286
Raw materials	105,739	112,010
Total inventory	$ 446,575	$ 159,472

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Depreciation and Amortization Periods for Fixed Assets) (Details)	12 Months Ended
	Dec. 31, 2020
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Machinery [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years or lease term
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Land improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Website Development [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Fixed assets) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,160,907	$ 820,303
Accumulated depreciation	(140,872)	(48,307)
Balance	1,020,035	771,996
Depreciation	117,340	17,143
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	15,780	7,268
Machinery [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	667,536	578,347
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	161,579	137,217
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	71,292	62,926
Land improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,270	7,270
Website Development [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,500	27,275
Construction in process [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 234,950

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued expenses) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Accrued payroll and taxes	$ 76,031	$ 321,328
Accrued interest	88,147	98,091
Credit cards payable	4,752	49,715
Other accrued expenses	28,420	20,045
Total accrued expenses	$ 197,350	$ 489,179

SUMMARY OF SIGNIFICANT ACCOUN_9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accrued legal liability) (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Apr. 22, 2015
Accounting Policies [Abstract]
Accrued consulting fees	$ 315,000	$ 315,000
Judgement payable	388,867	388,867
Accrued interest on judgement	105,260	86,739	$ 388,866
Total accrued legal liability	$ 809,127	$ 790,606

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Dilutive Shares Not Included in Loss Per Share Computation) (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	155,696,284	35,876,275
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	4,542,500	5,042,500
Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	38,920,378	29,849,761
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	112,233,406	984,014

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected price volatility, minimum		118.66%
Expected price volatility, maximum		152.63%
Risk-free interest rate, minimum		2.32%
Risk-free interest rate, maximum		2.41%
Dividend yield
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life in years	0 years	4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life in years	0 years	10 years

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Income Taxes Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Valuation allowance	$ 5.3
Operating loss carryforwards	21
Increase in valuation allowance		$ 0.7
Federal net operating losses	8
Federal net operating losses expired amount if not utilized	$ 13
Minimum [Member]
Operating loss carryforwards expiration dates	Dec. 31, 2031
Maximum [Member]
Operating loss carryforwards expiration dates	Dec. 31, 2037

SUMMARY OF SIGNIFICANT ACCOU_13

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Provision of Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Federal tax at statutory rate	$ (743)	$ (823)
State taxes, net of federal income tax benefit		(171)
Change of valuation allowance	731	987
Non-deductible expenses and other	12	7
Provision for income tax

SUMMARY OF SIGNIFICANT ACCOU_14

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Net operating loss carryforwards	$ 4,413	$ 3,610
Accruals and allowances	34	10
Stock-based compensation	1,070	1,059
Total deferred tax assets	5,517	4,679
Valuation allowance	(5,517)	(4,679)
Total deferred tax assets net of valuation allowance
Deferred tax liabilities:
Property, equipment and intangible assets	(180)	(57)
Total deferred tax liabilities	(180)	(57)
Valuation allowance	180	57
Total deferred tax liabilities net of valuation allowance
Net deferred tax assets

OPERATING LEASE (Narrative) (De

OPERATING LEASE (Narrative) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 25, 2019	Dec. 31, 2020	Dec. 31, 2019
Lessee Disclosure [Abstract]
Present value of lease payments		$ 1,405,804
Weighted average discount rate		15.00%
Operating lease rent expense		$ 429,022	$ 423,121
Lease term	1 year 9 months	3 years 2 months 30 days
Base rent obligation	$ 33,825

OPERATING LEASE (Schedule of Fu

OPERATING LEASE (Schedule of Future Minimum Lease Payments under Operating Lease) (Details)	Dec. 31, 2020USD ($)
Operating leases
2021	$ 415,033
2022	427,484
2023	440,308
2024	110,884
Total minimum lease payments	1,393,709
Discount	(300,032)
Operating lease liability	$ 1,093,677

NOTES PAYABLE - CONVERTIBLE (Na

NOTES PAYABLE - CONVERTIBLE (Narrative) (Details) - USD ($)	Jan. 11, 2021	Dec. 02, 2020	Aug. 03, 2020	Aug. 03, 2020	Jun. 05, 2020	Jun. 02, 2020	Apr. 13, 2020	Mar. 05, 2020	Oct. 10, 2019	Jun. 13, 2018	May 03, 2018	Jul. 21, 2020	Jun. 26, 2020	Jun. 26, 2020	May 29, 2020	May 27, 2020	Apr. 16, 2020	Oct. 22, 2015	Dec. 31, 2020	Dec. 31, 2019	Feb. 16, 2021	Apr. 22, 2018
Debt Instrument [Line Items]
Interest expense											$ 5,000								$ 5,041	$ 7,675
Accrued interest																			$ 760	86,520
Common Share issued																			7,110,340
Secured note payable per month																						$ 5,000
Note payable - convertible																			$ 10,000	$ 453,991
Par value of share																			$ 0.001	$ 0.001
Warrants term																			5 years
Exercise price of warrants																			$ 0.30
Repayments of convertible debt																			$ 348,000	$ 104,704
Proceeds from convertible debt																			1,620,000	408,000
Accrued interest																			0	11,244
Amount of debt conversion																				531,100
Net proceeds from note																			266,727	234,760
Subsequent Event [Member]
Debt Instrument [Line Items]
Common Share issued	600,000
Restricted Stock [Member]
Debt Instrument [Line Items]
Common Share issued										274,575
Unsecured convertible promissory note with Accredited Investor [Member]
Debt Instrument [Line Items]
Interest rate			18.00%	18.00%
Conversion price			$ 0.01	$ 0.01
Par value of share			$ 0.001	0.001
Proceeds from convertible debt			$ 500,000
Debt maturity			Feb. 3, 2021
Amount of debt conversion			$ 10,000
Unsecured convertible promissory note with Accredited Investor [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Accrued interest																					$ 1,007
Principal amount																					$ 10,000
Securities Purchase Agreement with Labrys Fund [Member]
Debt Instrument [Line Items]
Common Share issued																	1,300,000
Shares of common stock																	21,666,666
Convertible promissory note with Accredited investor [Member]
Debt Instrument [Line Items]
Interest rate								10.00%
Conversion price					$ 0.80							$ 0.132
Note payable - convertible												$ 50,000
Debt term								9 months
Par value of share					$ 0.001
Proceeds from warrant issued					$ 50,000
Warrants term					5 years							5 years
Debt conversion shares												393,246
Warrants issued												126,263
Exercise price of warrants												$ 0.396
Proceeds from convertible debt								$ 50,000
Accrued interest												$ 1,908
Debt discount contingent beneficial conversion feature					$ 50,000
Convertible Promissory Notes [Member]
Debt Instrument [Line Items]
Interest rate							12.00%
Conversion price							$ 0.092
Warrants term							5 years
Exercise price of warrants							$ 0.312
Proceeds from convertible debt							$ 100,000
Trading price of warrants							$ 0.69
Debt discount contingent beneficial conversion feature							$ 100,000
Convertible Promissory Notes [Member] | Noteholders [Member]
Debt Instrument [Line Items]
Warrants term												5 years	5 years
Debt conversion shares												280,532	556,313
Warrants issued												280,532	556,313
Exercise price of warrants												$ 0.312	$ 0.312	$ 0.312
Proceeds from convertible debt												$ 25,000	$ 50,000
Accrued interest												$ 1,618	$ 1,181	$ 1,181
Convertible promissory note with Accredited investor [Member]
Debt Instrument [Line Items]
Interest rate							12.00%								12.00%	12.00%
Conversion price							$ 0.132								$ 0.108	$ 0.11
Debt term												6 months			6 months	6 months
Par value of share							$ 0.001
Warrants term												5 years		5 years		5 years
Debt conversion shares												391,023		545,455
Warrants issued												391,023		545,455
Exercise price of warrants												$ 0.396	$ 0.33	$ 0.33	$ 0.324	$ 0.33
Proceeds from convertible debt							$ 50,000					$ 50,000			$ 50,000	$ 60,000
Accrued interest												$ 1,615	$ 552	$ 552
Trading price of warrants															$ 0.81	$ 0.825
Debt discount contingent beneficial conversion feature							$ 50,000								$ 50,000	$ 60,000
Convertible promissory note with Accredited investor Two [Member]
Debt Instrument [Line Items]
Warrants term														5 years
Debt conversion shares														462,963
Warrants issued														462,963
Exercise price of warrants													$ 0.324	$ 0.324
Proceeds from convertible debt														$ 50,000
Accrued interest													$ 427	$ 427
Convertible promissory note with Accredited investor [Member]
Debt Instrument [Line Items]
Interest rate						12.00%
Conversion price						$ 0.096
Debt term						6 months
Warrants term		5 years				5 years
Debt conversion shares		520,834
Warrants issued		520,834
Exercise price of warrants		$ 0.288				$ 0.288
Proceeds from convertible debt						$ 100,000
Accrued interest		$ 5,986
Trading price of warrants						$ 0.72
Debt discount contingent beneficial conversion feature						$ 100,000
Amount of debt conversion		$ 100,000
Unsecured Convertible Promissory Note[Member]
Debt Instrument [Line Items]
Unsecured promissory note																		$ 300,000
Interest rate																		7.00%
Conversion price			$ 0.175	$ 0.175														$ 0.35
Common Share issued				2,061,143
Debt term																		190 days
Loss on extinguishment of debt				$ 121,607
Accrued interest			$ 102,176	102,176
Principal amount			$ 258,524	$ 258,524
15% Convertible Promissory Note [Member] | Securities Purchase Agreement with Labrys Fund [Member]
Debt Instrument [Line Items]
Interest rate									15.00%
Common Share issued									1,300,000
Debt description									If the note is not repaid prior to the maturity date, the per share conversion price into which the principal amount and interest under the note may be converted is equal to the lesser of (i) 60% multiplied by the lowest trade price of the common stock during the 25 consecutive trading days ending on the latest complete trading day prior to the date of issuance of the note, and (ii) 60% multiplied by the lowest market price of the common stock during the 25 trading day period ending on the latest complete trading day prior to the conversion date.
Par value of share									$ 0.10
Accrued interest									$ 24,389
Debt maturity									Apr. 16, 2020
Principal amount									$ 338,000
Net proceeds from note									300,000
Original issue discount									33,800
Legal counsel fees									4,200
Repayment of notes payable									$ 262,389
Note Payable related party - convertible [Member]
Debt Instrument [Line Items]
Interest expense																			$ 64,093	$ 51,015

NOTES PAYABLE - CONVERTIBLE -_2

NOTES PAYABLE - CONVERTIBLE - RELATED PARTY (Narrative) (Details) - USD ($)	Feb. 12, 2021	Aug. 03, 2020	Jun. 05, 2020	Jun. 05, 2020	Apr. 13, 2020	May 03, 2018	Feb. 16, 2021	Jul. 21, 2020	Jul. 21, 2020	Jun. 26, 2020	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Notes payable - convertible - related party											$ 1,025,000
Proceeds from convertible debt											1,620,000	408,000
Accrued interest											$ 0	$ 11,244
Par value of share											$ 0.001	$ 0.001
Warrants term											5 years
Exercise price of warrants											$ 0.30
Interest rate											1.00%
Interest expense						$ 5,000					$ 5,041	$ 7,675
Amount of debt conversion												531,100
Convertible promissory note with Michael V. Barbera [Member]
Debt Instrument [Line Items]
Proceeds from convertible debt					$ 50,000			$ 50,000		$ 50,000
Accrued interest								$ 2,826	$ 2,826	$ 2,440
Conversion price					$ 0.132
Par value of share					$ 0.001
Conversion rate			80.00%
Warrants term			5 years					5 years		5 years
Debt conversion shares								400,195		397,269
Warrants issued								400,195		397,269
Exercise price of warrants								$ 0.396	$ 0.396	$ 0.396
Debt discount contingent beneficial conversion feature					$ 100,000
Convertible promissory note with Michael V. Barbera [Member] | Minimum [Member]
Debt Instrument [Line Items]
Interest rate					10.00%
Convertible promissory note with Michael V. Barbera [Member] | Maximum [Member]
Debt Instrument [Line Items]
Interest rate					12.00%
Demand note agreement with Michael V. Barbera Two [Member]
Debt Instrument [Line Items]
Proceeds from convertible debt					$ 25,000				$ 25,000
Accrued interest								$ 809	$ 809
Conversion price					$ 0.132
Par value of share					$ 0.001
Conversion rate				80.00%
Warrants term					5 years				5 years
Debt conversion shares									195,522
Warrants issued									195,522
Exercise price of warrants								$ 0.396	$ 0.396
Interest rate					12.00%
Debt discount contingent beneficial conversion feature					$ 25,000
Convertible promissory note with Ronald J. LoRicco [Member]
Debt Instrument [Line Items]
Proceeds from convertible debt					$ 150,000
Accrued interest										$ 3,542
Conversion price					$ 0.132
Par value of share					$ 0.001
Conversion rate				80.00%
Warrants term					5 years					5 years
Debt conversion shares										1,163,201
Warrants issued										1,163,201
Exercise price of warrants										$ 0.396
Interest rate					12.00%
Debt discount contingent beneficial conversion feature					$ 150,000					$ 150,000
Unsecured convertible promissory note with Michael V. Barbera [Member]
Debt Instrument [Line Items]
Proceeds from convertible debt		$ 25,000
Conversion price		$ 0.01
Par value of share		$ 0.001
Interest rate		18.00%
Amount of debt conversion		$ 500,000
Unsecured convertible promissory note with Michael V. Barbera [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Accrued interest							$ 2,518
Amount of debt conversion							$ 25,000
Demand notes payable from related parties [Member]
Debt Instrument [Line Items]
Conversion rate			80.00%
Secured convertible promissory note agreements with Related Party [Member]
Debt Instrument [Line Items]
Proceeds from convertible debt		$ 500,000
Conversion price		$ 0.01
Par value of share		$ 0.001
Interest rate		20.00%
Debt maturity		Feb. 3, 2021
Amount of debt conversion		$ 1,000,000
Secured convertible promissory note agreements with Related Party [Member] | Louis Demaio as Trustee [Member]
Debt Instrument [Line Items]
Debt principal amount		$ 750,000
Secured convertible promissory note agreements with Related Party [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Accrued interest	$ 110,005
Conversion rate	20.00%
Interest rate	20.00%
Debt maturity	May 12, 2021
Amount of debt conversion	$ 1,610,005
Debt principal amount	$ 1,207,504
Note Payable related party - convertible [Member]
Debt Instrument [Line Items]
Accrued interest											86,574	0
Interest expense											$ 93,736	$ 4,704

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)	Jan. 11, 2021	Jan. 04, 2021	Jul. 08, 2020	May 03, 2020	May 03, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Sep. 03, 2019
Debt Instrument [Line Items]
Notes payable						$ 128,021	$ 219,617
Accrued interest						$ 0	11,244
Interest rate						1.00%
Interest expense					$ 5,000	$ 5,041	7,675
Proceeds from convertible debt						$ 1,620,000	$ 408,000
Shares issued						7,110,340
Exercise price of warrants						$ 0.30
Warrants term						5 years
Subsequent Event [Member]
Debt Instrument [Line Items]
Shares issued	600,000
Unsecured Convertible Promissory Note[Member]
Debt Instrument [Line Items]
Accrued interest			$ 15,729
Proceeds from convertible debt			$ 191,965
Shares issued			150,000
Debt conversion shares			1,136,364
Amount of debt forgiven			$ 57,694
Conversion price			$ 0.132
Exercise price of warrants			$ 0.396
Warrants term			5 years
Financing arrangements [Member]
Debt Instrument [Line Items]
Accrued interest						$ 4,703
Interest rate						9.40%			7.00%
Principal Amount						$ 0
Promissory note agreement with bank [Member]
Debt Instrument [Line Items]
Interest rate				1.00%
Promissory note				$ 123,318
Promissory note agreement with bank [Member] | Subsequent Event [Member]
Debt Instrument [Line Items]
Forgiven promissory note		$ 123,318
VCVC, LLC [Member] | Unsecured Convertible Promissory Note[Member]
Debt Instrument [Line Items]
Interest rate								4.00%
Proceeds from unsecured debt								$ 260,425

NOTES PAYABLE - RELATED PARTY (

NOTES PAYABLE - RELATED PARTY (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jan. 16, 2020	Dec. 31, 2020	Dec. 31, 2019	Jun. 05, 2020	Apr. 13, 2020
Debt Instrument [Line Items]
Notes payable - related party		$ 0	$ 0
Interest rate		1.00%
Michael V. Barbera [Member]
Debt Instrument [Line Items]
Demand notes	$ 50,000
Interest rate	10.00%
Debt term	6 months
Discount rate				20.00%
Michael V. Barbera [Member] | Convertible Promissory Notes [Member]
Debt Instrument [Line Items]
Interest rate					12.00%
Ronald J. LoRicco [Member]
Debt Instrument [Line Items]
Demand notes	$ 50,000
Interest rate	10.00%
Debt term	6 months
Discount rate				20.00%
Ronald J. LoRicco [Member] | Convertible Promissory Notes [Member]
Debt Instrument [Line Items]
Interest rate					12.00%
Notes Payable [Member]
Debt Instrument [Line Items]
Notes payable - related party		$ 0	0
Interest expense		$ 2,455	$ 2,926

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Mar. 18, 2020	Oct. 22, 2020	Jul. 23, 2020	Feb. 26, 2020	Dec. 31, 2020	Dec. 31, 2019	Apr. 22, 2015
Other Commitments [Line Items]
Default amount, payable for settlement					$ 41,937
Accelerated rent and damages					376,424
Attorney costs					$ 12,442
Accrued interest percentage rate					4.75%
Accrued interest on judgement					$ 105,260	$ 86,739	$ 388,866
Claims settlement amount				$ 125,000
Net proceeds received	$ 70,817
Agreement with MEP [Member]
Other Commitments [Line Items]
Agreement amount			$ 50,000,000
Agreement period			5 years
Options to purchase restricted common shares			5,000,000
Options to purchase restricted common shares, period			5 years
Agreement with CRBC [Member]
Other Commitments [Line Items]
Agreement amount		$ 50,000,000
Agreement period		5 years
Options to purchase restricted common shares		5,000,000
Options to purchase restricted common shares, period		5 years

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - USD ($)

Oct. 14, 2020

Oct. 05, 2020

Aug. 05, 2020

Dec. 04, 2020

Oct. 27, 2020

Oct. 16, 2020

Sep. 28, 2020

Sep. 25, 2020

Apr. 30, 2020

Jun. 30, 2020

Dec. 31, 2020

Dec. 31, 2019

Class of Stock [Line Items]

Shares issued

7,110,340

Shares issued value

$ 1,142,992

$ 1,270,080

Common stock, par value per share

$ 0.001

$ 0.001

Strike price of warrants

$ 0.30

Proceeds from warrant exercises

$ 654,076

Deemed dividends

$ (663,501)

$ (388,932)

Debt conversion value

$ 531,100

Restricted Common Shares [Member]

Class of Stock [Line Items]

Shares issued

6,590,340

Original strike price of warrants

$ 7,110,340

Proceeds from warrant exercises

$ 654,076

Conversion of stock value

$ 612,576

Deemed dividends

663,501

Debt conversion shares

9,305,426

Debt conversion value

$ 1,104,476

Shares issued for services, shares

600,000

Stock repurchased

1,300,000

Restricted Common Shares [Member] | Private Placement [Member]

Class of Stock [Line Items]

Conversion of stock value

$ 320,325

Restricted Common Shares [Member] | Warrant [Member]

Class of Stock [Line Items]

Conversion of stock shares

1,601,632

Investors [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Shares issued

4,166,667

Shares issued value

$ 416,667

Common stock, par value per share

$ 0.001

Warrants issued

4,000,000

Strike price of warrants

$ 0.30

Warrants term

5 years

Investors [Member] | Restricted Common Shares [Member] | Transaction One [Member]

Class of Stock [Line Items]

Warrants issued

16,667

Strike price of warrants

$ 0.40

Warrants term

5 years

Debt with Labrys Fund [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Shares issued

1,300,000

Investors One [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Stock issued per share

$ 0.1096

Shares issued

912,409

Shares issued value

$ 200,000

Common stock, par value per share

$ 0.001

Warrants term

5 years

Two Investors [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Stock issued per share

$ 0.104

Shares issued

961,538

Common stock, par value per share

$ 0.001

Warrants term

5 years

Accredited investors [Member]

Class of Stock [Line Items]

Shares issued

163,043

Shares issued value

$ 30,000

Warrants issued

163,043

Strike price of warrants

$ 0.54

Warrants term

5 years

Accredited investors [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Shares issued

166,667

300,000

133,333

300,000

500,000

Shares issued value

$ 90,000

Strike price of warrants

$ 0.075

Conversion of stock value

$ 50,000

$ 90,000

$ 40,000

$ 37,500

Consulting Agreement [Member]

Class of Stock [Line Items]

Shares issued

600,000

Shares issued value

$ 174,000

Accredited Investors and Related Parties [Member] | Restricted Common Shares [Member]

Class of Stock [Line Items]

Shares issued

8,385,289

Shares issued value

$ 1,142,992

OPTIONS AND WARRANTS (Narrative

OPTIONS AND WARRANTS (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Strike price of warrants	$ 0.30
Warrants term	5 years
Proceeds from exercise of warrants	$ 654,076
Common Share issued	7,110,340
Execution of the warrants agreement	$ 7,500
Cashless of the warrants agreement	250,000
Monthly payments	7,500
Stock-based compensation expense	165,590	$ 1,701,316
Stock issued but not earned as compensation	$ 8,410
Stock Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants to purchase common stock	500,000
Strike price of warrants	$ 0.075
Proceeds from exercise of warrants	$ 37,500
Stock Warrants One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants to purchase common stock	6,610,340
Percentage of discount of warrants exercises	50.00%
Proceeds from exercise of warrants	$ 616,576

OPTIONS AND WARRANTS (Schedule

OPTIONS AND WARRANTS (Schedule of Activity in Options and Warrants) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stock Options [Member]
Total Options Warrants Outstanding
Balance at December 31,	5,042,500	2,587,500
Issued		2,500,000
Cancelled	(500,000)	(45,000)
Balance at December 31,	4,542,500	5,042,500
Weighted Average Exercise Price
Balance at December 31,	$ 0.40	$ 0.35
Issued		0.25
Cancelled	(0.25)	(0.25)
Balance at December 31,	$ 0.41	$ 0.40
Aggregate Intrinsic Value
Balance at December 31,	$ 118,148
Stock Warrants [Member]
Total Options Warrants Outstanding
Balance at December 31,	29,849,761	18,025,000
Granted	17,180,957	31,535,475
Exercised	(7,110,340)	(19,710,714)
Cancelled	(1,000,000)
Balance at December 31,	38,920,378	29,849,761
Weighted Average Exercise Price
Balance at December 31,	$ 0.23	$ 0.24
Granted	0.31	0.12
Exercised	0.09	0.07
Cancelled
Balance at December 31,	$ 0.27	$ 0.23
Aggregate Intrinsic Value
Balance at December 31,	$ 2,973,660	$ 1,956,750

OPTIONS AND WARRANTS (Schedul_2

OPTIONS AND WARRANTS (Schedule of Options and Warrants Exercisable and Outstanding) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Stock Options [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number Outstanding	4,542,500	5,042,500	2,587,500
Weighted Average Exercise Price	$ 0.41	$ 0.40	$ 0.35
Average Intrinsic Value	$ 118,148
Stock Options [Member] | $0.01 - $0.50 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Number Outstanding	2,002,500
Weighted Average Remaining Contractual Life (Years)	2 years 7 months 28 days
Weighted Average Exercise Price	$ 0.25
Average Intrinsic Value	$ 118,148
Stock Options [Member] | $0.51 - $1.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower	$ 0.51
Range of Exercise Prices, Upper	$ 1
Number Outstanding	2,540,000
Weighted Average Remaining Contractual Life (Years)	4 years 9 months 18 days
Weighted Average Exercise Price	$ 0.54
Average Intrinsic Value
Stock Warrants [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number Outstanding	38,920,378	29,849,761	18,025,000
Weighted Average Exercise Price	$ 0.27	$ 0.23	$ 0.24
Average Intrinsic Value	$ 2,973,660	$ 1,956,750
Stock Warrants [Member] | $0.01 - $0.50 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Number Outstanding	36,429,835
Weighted Average Remaining Contractual Life (Years)	3 years 5 months 16 days
Weighted Average Exercise Price	$ 0.24
Average Intrinsic Value	$ 2,973,660
Stock Warrants [Member] | $0.51 - $1.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower	$ 0.51
Range of Exercise Prices, Upper	$ 1
Number Outstanding	2,490,543
Weighted Average Remaining Contractual Life (Years)	2 years 1 month 6 days
Weighted Average Exercise Price	$ 0.60
Average Intrinsic Value

RELATED PARTIES (Details)

RELATED PARTIES (Details) - USD ($)	1 Months Ended	12 Months Ended
	Nov. 20, 2020	Dec. 31, 2020
Related Party Transaction [Line Items]
Warrants exercise price		$ 0.30
Purchased discounted restricted common shares		11,632
Purchased discounted restricted common value		$ 2,326
Discounted restricted common shares per share		$ 0.20
Investors [Member]
Related Party Transaction [Line Items]
Warrants exercise price percentage	50.00%
Paul Sallarulo [Member] | Board of Directors [Member]
Related Party Transaction [Line Items]
Number of warrants exercised	2,000,000
Warrants exercise price	$ 0.075
Exercise of warrants issued	$ 75,000
Exercise of warrants issued per share	$ 0.0375
Michael V. Barbera [Member] | Chairman [Member]
Related Party Transaction [Line Items]
Number of warrants exercised	1,000,000
Warrants exercise price	$ 0.075
Exercise of warrants issued	$ 37,500
Exercise of warrants issued per share	$ 0.0375
Ronald J. LoRicco, Sr. [Member] | Board of Directors [Member]
Related Party Transaction [Line Items]
Number of warrants exercised	1,163,201
Warrants exercise price	$ 0.396
Exercise of warrants issued	$ 230,314
Exercise of warrants issued per share	$ 0.198

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Feb. 12, 2021	Feb. 11, 2021	Jan. 11, 2021	Aug. 03, 2020	Mar. 29, 2021	Jan. 26, 2021	Dec. 04, 2020	Dec. 31, 2020	Dec. 31, 2019	Feb. 25, 2021	Jan. 04, 2021
Subsequent Event [Line Items]
Shares issued								7,110,340
Shares issued, value								$ 1,142,992	$ 1,270,080
Strike price of warrants								$ 0.30
Subscription liability								$ 40,000
Notes payable								$ 128,021	219,617
Interest rate								1.00%
Accrued interest								$ 0	11,244
Amount of debt conversion									$ 531,100
Par value per share								$ 0.001	$ 0.001
Proceeds from convertible debt								$ 1,620,000	$ 408,000
Restricted Common Shares [Member]
Subsequent Event [Line Items]
Shares issued							6,590,340
Amount of debt conversion								1,104,476
Accredited Investor [Member] | Restricted Common Shares [Member]
Subsequent Event [Line Items]
Subscription liability								$ 40,000
Secured convertible promissory note agreements with Related Party [Member]
Subsequent Event [Line Items]
Interest rate				20.00%
Amount of debt conversion				$ 1,000,000
Debt maturity				Feb. 3, 2021
Par value per share				$ 0.001
Proceeds from convertible debt				$ 500,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Shares issued			600,000
Shares issued, value			$ 174,000
Subsequent Event [Member] | Accredited Investor [Member] | Restricted Common Shares [Member]
Subsequent Event [Line Items]
Shares issued					127,128	200,000
Shares issued, value					$ 23,900
Number of warrants exercised						1,000,000
Proceeds from exercise of warrants						$ 123,500
Strike price of warrants						$ 0.1235
Subsequent Event [Member] | Accredited Investor [Member] | Unestricted Common Shares [Member]
Subsequent Event [Line Items]
Shares issued		250,000
Shares issued, value		$ 50,000
Subsequent Event [Member] | Paycheck Protection Program [Member]
Subsequent Event [Line Items]
Notes payable											$ 123,381
Accrued interest											$ 825
Subsequent Event [Member] | Promissory note agreement with bank [Member]
Subsequent Event [Line Items]
Notes payable										$ 165,747
Interest rate										1.00%
Subsequent Event [Member] | Secured convertible promissory note agreements with Related Party [Member]
Subsequent Event [Line Items]
Number of warrants exercised	11,250,000
Notes payable	$ 1,000,000
Interest rate	20.00%
Accrued interest	$ 110,005
Agreement period	5 years
Amount of debt conversion	$ 1,610,005
Additional notes payable	$ 500,000
Conversion rate	20.00%
Debt maturity	May 12, 2021
Debt principal amount	$ 1,207,504
Subsequent Event [Member] | Secured convertible promissory note agreements with Related Party [Member] | Noteholders [Member]
Subsequent Event [Line Items]
Number of warrants exercised	15,000,000
Strike price of warrants	$ 0.20
Proceeds from convertible debt	$ 3,000,000
Subsequent Event [Member] | Secured convertible promissory note agreements with Related Party [Member] | Third-party investor [Member]
Subsequent Event [Line Items]
Conversion rate	1.00%
Par value per share	$ 0.001
Proceeds from convertible debt	$ 500,000